Business
The world is hungry for mRNA COVID vaccines like Pfizer’s. But we’re short of vital components – The Conversation AU
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Pfizers mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before years end.
But Australia isnt the only country eager to get its hand on this vaccine.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of this and other mRNA…
-
Noosa News24 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business21 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News19 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Business19 hours agoThe best ASX shares to buy and forget for 10+ years